• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
MRKR

MRKR

Marker Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD1.45

+0.03 (+2.11%)

Rating:C

Company Profile

CEO

Juan F. Vera

IPO Date

2002-07-16

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$1.44

Prev. Close

$1.42

Day Low

$1.44

Day High

$1.46

52W Low

$0.81

52W High

$4.07

Market Cap

$0.02B

Volume

0.02M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

48.9%

Avg Negative

2.0%

Avg Neutral

48.9%

News Feed

Marker Therapeutics Announces Opening of New cGMP Manufacturing Facility

PRNewsWire·7/28/2021·↑ positive

Marker Therapeutics Announces Completion of Safety Lead-In Portion of Phase 2 Study in Post-Transplant AML

PRNewsWire·7/6/2021·↑ positive

Marker Therapeutics to Present at the Virtual Raymond James Human Health Innovation Conference

PRNewsWire
·6/16/2021
·↑ positive

Marker Therapeutics, Inc. (MRKR) CEO Peter Hoang on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/12/2021·↓ negative

Marker Therapeutics Reports First Quarter 2021 Operating and Financial Results

PRNewsWire·5/12/2021·↑ positive

Marker Therapeutics to Present Multi-Tumor-Associated Antigen (mTAA)-Specific T Cell Manufacturing Robotics Data at the 2021 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

PRNewsWire·4/27/2021·↑ positive

Marker Therapeutics Gets A 'Thumbs Up'

Seeking Alpha·4/25/2021·↑ positive

Marker Therapeutics: Undervalued Cancer Therapeutics With High Potential

Seeking Alpha·4/23/2021·↑ positive

10 Reddit Penny Stocks Seeing the Most Chatter Today

InvestorPlace·3/22/2021·↑ positive

MRKR Stock Price Increases Over 15% Pre-Market: Why It Happened

Pulse2·3/22/2021·↑ positive